Zai Lab Ltd (ZLAB)

147.52 +0.13  +0.09% NASDAQ Feb 26, 20:00 USD
View Full Chart
Price Chart
View All ZLAB News

News

View All Events

Events

Date Type Description
03/01/2021 Earnings Zai Lab Ltd Third Quarter Earnings Result for 2020
03/01/2021 08:00 EST Misc Zai Lab Ltd Third Quarter Earnings Conference Call for 2020
08/13/2020 08:00 EDT Misc Zai Lab Ltd Second Quarter Earnings Conference Call for 2020
08/13/2020 Earnings Zai Lab Ltd Second Quarter Earnings Result for 2020
04/29/2020 Misc Zai Lab Ltd Annual Report for 2019
03/19/2020 08:30 EDT Misc Zai Lab Ltd Fourth Quarter Earnings Conference Call for 2019
03/19/2020 Earnings Zai Lab Ltd Fourth Quarter Earnings for 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.zailaboratory.com
  • Investor Relations URL: N/A
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Large Cap/Growth
  • Next Earnings Release: Mar. 01, 2021
  • Last Earnings Release: Aug. 13, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatment across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC. The other product candidate includes Fugan, ZL-2302, and ZL-1101. The company operates through the segment being Developing and commercializing proprietary therapeutics.

Top Fund Holders

Symbol Name Weighting
CHB Global X China Biotech Innovation ETF 7.39%
CHIH Global X MSCI China Health Care ETF 5.44%
GERM ETFMG Treatments Testing and Adv ETF 4.66%
KURE KraneShares MSCI All China Hlth Care ETF 2.83%
BEXUX Baron Emerging Markets R6 2.64%
PGJ Invesco Golden Dragon China ETF 2.50%
BGLUX Baron Global Advantage R6 1.87%
HGHVX Hartford Healthcare R6 1.68%
FKBSX Federated Hermes Kaufmann Small Cap B 1.50%
KAUBX Federated Hermes Kaufmann B 1.42%
CNWFX American Funds New World 529F 1.24%
MEE.TO Mackenzie Maximum Divers Emerg Mkts ETF 0.63%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.